C. Gerlinger

C. Gerlinger, T. Faustmann, T. Strowitzki, 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study

C. Gerlinger, T. Faustmann, K. Becker, 2021, Journal of Endometriosis and Pelvic Pain Disorders.

Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study

C. Gerlinger, T. Faustmann, K. Becker, 2020, Advances in Therapy.

Serum C-reactive protein as potential independent prognostic factor for breast cancer

C. Gerlinger, E. Solomayer, C. Scholz, 2015 .

Original research article A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 go r 30g ethinylestradiol in combination with levonorgestrel on bone mineral density

D. Felsenberg, C. Gerlinger, J. Endrikat, 2004 .

A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density.

D. Felsenberg, C. Gerlinger, J. Endrikat, 2004, Contraception.

A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.

C. Gerlinger, J. Endrikat, C. Kluft, 2006, Contraception.

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression

C. Gerlinger, C. Liedtke, E. Solomayer, 2014, Archives of Gynecology and Obstetrics.

Vaginal operative delivery in Germany: a national survey about experience and self-reported competency

C. Gerlinger, E. Solomayer, J. Lavin, 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2005, Contraception.

Using Real‐World Data to Extrapolate Evidence From Randomized Controlled Trials

J. Gagne, S. Schneeweiss, C. Gerlinger, 2018, Clinical pharmacology and therapeutics.

A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17&bgr;-estradiol for moderate to severe vasomotor symptoms in postmenopausal women

C. Gerlinger, D. Archer, T. Schmelter, 2014, Menopause.

Pattern recognition in menstrual bleeding diaries by statistical cluster analysis

C. Gerlinger, J. Endrikat, G. Kallischnigg, 2009, BMC women's health.

Generalizability of randomized controlled trials in heart failure with reduced ejection fraction

B. Tyl, A. Hoes, D. Grobbee, 2021 .

Is vimentin a potential prognostic factor for patients with triple-negative breast cancer?

C. Gerlinger, R. Bohle, J. Endrikat, 2020, Journal of Cancer Research and Clinical Oncology.

Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.

J. Brazier, Jennifer Roberts, C. Gerlinger, 2017, Investigative ophthalmology & visual science.

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.

C. Gerlinger, J. Trussell, J. Endrikat, 2014, Contraception.

The potential role of preoperative serum cancer antigen CA 15-3 in the prognosis of breast cancer

C. Gerlinger, E. Solomayer, C. Scholz, 2015 .

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.

C. Gerlinger, J. Endrikat, U. Gaspard, 2004, Contraception.

Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis

Christoph Gerlinger, James D. Chalmers, Giovanni Sotgiu, 2018, American journal of respiratory and critical care medicine.

A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.

C. Gerlinger, J. Endrikat, J. Jespersen, 2005, Contraception.

Original research article A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 Ag of ethinylestradiol and 100 Ag of levonorgestrel with 30 Ag of ethinylestradiol and 100 Ag of levonorgestrel B

C. Gerlinger, J. Endrikat, J. Jespersen, 2005 .

Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.

M. Krempf, C. Gerlinger, V. Rohmer, 2000, Diabetes & metabolism.

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, Contraception.

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.

C. Gerlinger, J. Endrikat, C. Klipping, 2002, Contraception.

Generalizability of randomized controlled trials in heart failure with reduced ejection fraction

B. Tyl, A. Hoes, L. Lund, 2021, European heart journal. Quality of care & clinical outcomes.

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17&bgr;-estradiol in postmenopausal women with moderate to severe vasomotor symptoms

C. Gerlinger, D. Archer, T. Schmelter, 2014, Menopause.

Impact of body mass index, smoking habit, alcohol consumption, physical activity and parity on disease course of women with triple-negative breast cancer

C. Gerlinger, J. Endrikat, E. Solomayer, 2019, Archives of Gynecology and Obstetrics.

A systematic review of methods to measure menstrual blood loss

C. Gerlinger, C. Seitz, S. O’Brien, 2018, BMC Women's Health.

A drospirenone-containing oral contraceptive improved bleeding pattern and personal satisfaction in 914 women from Jordan, Lebanon and Syria

C. Gerlinger, J. Endrikat, E. Solomayer, 2013 .

Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women

C. Gerlinger, Emyr Davies, S. Kelly, 2010, Clinical drug investigation.

Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.

C. Gerlinger, J. Endrikat, W. Schmidt, 2009, Contraception.

A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 μg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

C. Gerlinger, J. Endrikat, Michel P Fortier, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Incidence of and risk factors for vaginal cuff dehiscence following total laparoscopic hysterectomy: a monocentric hospital analysis

C. Gerlinger, S. Wagenpfeil, Uda-Mareke Risius, 2021, Archives of Gynecology and Obstetrics.

Safety and perioperative morbidity of laparoscopic sacropexy: a systematic analysis and a comparison with laparoscopic hysterectomy

C. Gerlinger, S. Baum, J. Radosa, 2017, Archives of Gynecology and Obstetrics.

An empirically generated responder definition for rosacea treatment

C. Gerlinger, J. Endrikat, K. Shakery, 2017, Clinical, cosmetic and investigational dermatology.

Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries

C. Gerlinger, J. Endrikat, G. Kallischnigg, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.

J. Foidart, C. Gerlinger, W. Wuttke, 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001 .

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone

C. Gerlinger, J. Endrikat, W. Schmidt, 2001 .

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.

C. Gerlinger, J. Endrikat, W. Schmidt, 2001, Contraception.

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, Contraception.

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.

C. Gerlinger, J. Endrikat, T. Strowitzki, 1999, Contraception.

Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review

C. Gerlinger, C. Seitz, J. Magnay, 2020, BMC Women's Health.

Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers.

C. Gerlinger, C. Seitz, T. Nevatte, 2014, Fertility and sterility.

Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials

C. Gerlinger, T. Faustmann, C. Seitz, 2012, BMC Women's Health.

Postpartum Assessment of the Correlation between Serum Hormone Levels of Estradiol, Progesterone, Prolactin and ß-HCG and Blood Pressure Measurements in Pre-Eclampsia Patients

C. Gerlinger, E. Solomayer, L. Pleș, 2022, Diagnostics.

Comparison of Maternal Serum Levels and Placental mRNA Levels of Dickkopf-1 in Preeclamptic and Normal Pregnant Women at Delivery

C. Gerlinger, E. Solomayer, J. Radosa, 2021, Geburtshilfe und Frauenheilkunde.

Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women

David Bernuit, C. Gerlinger, Katharina Geppert, 2012, BMC Women's Health.

A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use

C. Gerlinger, J. Endrikat, B. Düsterberg, 2003, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

A pharmacokinetic study with a low-dose oral contraceptive containing 20 μg ethinylestradiol plus 100 μg levonorgestrel

C. Gerlinger, J. Endrikat, W. Kuhnz, 2002 .

Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases

C. Gerlinger, R. Bohle, E. Solomayer, 2018, Clinical & Experimental Metastasis.

Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2011, Contraception.

Determining the non‐inferiority margin for patient reported outcomes

C. Gerlinger, T. Schmelter, 2011, Pharmaceutical statistics.

Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program

C. Gerlinger, T. Faustmann, T. Strowitzki, 2015, International journal of women's health.

Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers

C. Gerlinger, T. Faustmann, D. Heger-Mahn, 2004, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Optimal dose de-escalation trial designs for novel contraceptives in women

Christoph Gerlinger, Oke Gerke, Jan Endrikat, 2012, Comput. Stat. Data Anal..

Urogynecology in obstetrics: impact of pregnancy and delivery on pelvic floor disorders, a prospective longitudinal observational pilot study

C. Gerlinger, E. Solomayer, G. Schmidt, 2021, Archives of Gynecology and Obstetrics.

Denial of pregnancy ‐ characteristics of women at risk

C. Gerlinger, J. Wessel, A. Gauruder‐Burmester, 2007, Acta obstetricia et gynecologica Scandinavica.

Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer

T. Fehm, C. Gerlinger, R. Bohle, 2016, Journal of Cancer Research and Clinical Oncology.

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.

C. Gerlinger, T. Faustmann, T. Strowitzki, 2010, Human reproduction.

Cervical and Lower Uterine Parameter Ultrasound and Elastographic Parameters for the Prediction of a Successful Induction of Labor

C. Gerlinger, E. Solomayer, J. Radosa, 2020, Ultraschall in der Medizin - European Journal of Ultrasound.

Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study.

C. Gerlinger, T. Faustmann, T. Strowitzki, 2010, European journal of obstetrics, gynecology, and reproductive biology.

Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate.

C. Gerlinger, V. El-Samalouti, M. Schaefers, 2009, European journal of obstetrics, gynecology, and reproductive biology.

A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen.

C. Gerlinger, J. Marr, M. Kunz, 2012, European journal of obstetrics, gynecology, and reproductive biology.

Recommendation for confidence interval and sample size calculation for the Pearl Index

C. Gerlinger, J. Endrikat, B. Düsterberg, 2003, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

J. Foidart, C. Gerlinger, G. Merki-Feld, 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Patient-reported outcomes in the context of the benefit assessment in Germany

Christoph Gerlinger, Kati Sternberg, Friedhelm Leverkus, 2021, 2107.03249.

Responsible data sharing in international health research: a systematic review of principles and norms

S. Kalkman, J. V. van Delden, M. Mostert, 2019, BMC medical ethics.

A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis

C. Gerlinger, T. Faustmann, A. Mueck, 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?

Frank Bretz, Christoph Gerlinger, Tim Friede, 2020, Statistics in biopharmaceutical research.

Estimation of menstrual blood loss volume based on menstrual diary and laboratory data

C. Gerlinger, A. Wienke, J. Endrikat, 2012, BMC Women's Health.

The use of external controls: To what extent can it currently be recommended?

C. Gerlinger, H. Burger, C. Harbron, 2021, Pharmaceutical statistics.

Muscle mass loss in patients with metastatic breast cancer

C. Gerlinger, J. Endrikat, E. Solomayer, 2019, Archives of Gynecology and Obstetrics.

Bleeding patterns with the 19.5 mg LNG-IUS, with special focus on the first year of use: implications for counselling

C. Gerlinger, A. Frenz, E. Lukkari-Lax, 2019, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems

T. Friede, C. Gerlinger, A. Frenz, 2020, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 microg ethinyl estradiol and 75 microg gestodene.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, Contraception.

Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)

C. Gerlinger, T. Willgoss, H. Kitchen, 2021, Health and Quality of Life Outcomes.

Validation of the SF-36 in patients with endometriosis

D. Stull, C. Gerlinger, R. Wasiak, 2009, Quality of Life Research.

Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly

C. Gerlinger, J. Endrikat, P. Lengsfeld, 2021, Investigative radiology.

On Testing Simultaneously Non‐inferiority in Two Multiple Primary Endpoints and Superiority in at Least One of Them

Christoph Gerlinger, Norbert Benda, Jürgen Läuter, 2006, Biometrical journal. Biometrische Zeitschrift.

Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter study.

C. Gerlinger, M. Kornitzer, M. Dramaix, 1994, Atherosclerosis.

0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes

C. Gerlinger, J. Endrikat, T. Schmelter, 2015, Climacteric : the journal of the International Menopause Society.

A Noninferiority Margin for Acne Lesion Counts

C. Gerlinger, J. Endrikat, G. Städtler, 2008 .

Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results

C. Gerlinger, J. Endrikat, C. Schwenke, 2019, BMC Research Notes.

Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up study

C. Gerlinger, T. Faustmann, T. Strowitzki, 2009 .

Development and content validation of two new patient-reported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)

C. Gerlinger, C. Seitz, C. Haberland, 2020, Journal of Patient-Reported Outcomes.

Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies

H. Doll, C. Gerlinger, C. Seitz, 2020, Journal of Patient-Reported Outcomes.

Introduction of a learning model for type 1 loop excision of the transformation zone of the uterine cervix in undergraduate medical students: a prospective cohort study

C. Gerlinger, E. Solomayer, J. Radosa, 2019, Archives of Gynecology and Obstetrics.

Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 g gestodene

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Efficacy and safety of two post-operative drains: results of a prospectively randomized clinical study in breast cancer patients after breast conserving surgery

C. Gerlinger, J. Endrikat, E. Solomayer, 2019, Archives of Gynecology and Obstetrics.

Sperm count as a surrogate endpoint for male fertility control

C. Gerlinger, N. Benda, 2007, Statistics in medicine.

A standardized simulation training program to type 1 loop electrosurgical excision of the transformation zone: a prospective observational study

C. Gerlinger, E. Solomayer, G. Breitbach, 2019, Archives of Gynecology and Obstetrics.

Patterns of missing data in the use of the endometriosis symptom diary

C. Gerlinger, F. Oehmke, H. Tinneberg, 2018, BMC Women's Health.

Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 g gestodene.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2001 .

Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis

C. Gerlinger, T. Faustmann, K. Becker, 2021, Scientific Reports.